Prophylactic oophorectomyCOUKOS, George; RUBIN, Stephen C.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2002, Vol 16, Num 4, pp 597-609, issn 1521-6934, 13 p.Article

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionCHU, Christina S; BOYER, Jean; VONDERHEIDE, Robert H et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 5, pp 629-641, issn 0340-7004, 13 p.Article

Secondary surgical cytoreduction for advanced ovarian carcinomaROSE, Peter G; NERENSTONE, Stacy; BRADY, Mark F et al.The New England journal of medicine. 2004, Vol 351, Num 24, pp 2489-2497, issn 0028-4793, 9 p.Article

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancerLIN ZHANG; CONEJO-GARCIA, Jose R; RUBIN, Stephen C et al.The New England journal of medicine. 2003, Vol 348, Num 3, pp 203-213, issn 0028-4793, 11 p.Article

Vascular leukocytes contribute to tumor vascularizationCONEJO-GARCIA, Jose R; BUCKANOVICH, Ronald J; BENENCIA, Fabian et al.Blood. 2005, Vol 105, Num 2, pp 679-681, issn 0006-4971, 3 p.Article

Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinomaLIN ZHANG; NUO YANG; COUKOS, George et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 264-272, issn 1078-0432, 9 p.Article

TRANCe- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patientsSCHLIENGER, Katia; CHU, Christina S; KAISER, Larry R et al.Clinical cancer research. 2003, Vol 9, Num 4, pp 1517-1527, issn 1078-0432, 11 p.Article

Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomyCHU, Christina S; RANDALL, Thomas C; BANDERA, Christina A et al.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp 62-65, issn 0090-8258, 4 p.Article

Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer riskREBBECK, Timothy R; TROXEL, Andrea B; RUBIN, Stephen C et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 18, pp 1311-1320, issn 0027-8874, 10 p.Article

Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinomaLIN ZHANG; NUO YANG; CONEJO GARCIA, Jose-Ramon et al.The American journal of pathology. 2002, Vol 161, Num 6, pp 2295-2309, issn 0002-9440, 15 p.Article

Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patientsCHU, Christina S; WOO, Edward Y; TOLL, Alanna J et al.Clinical immunology (Orlando, Fla. Print). 2001, Vol 102, Num 3, pp 291-301, issn 1521-6616Article

A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosisHAHN, Stephen M; FRAKER, Douglas L; PUTT, Mary et al.Clinical cancer research. 2006, Vol 12, Num 8, pp 2517-2525, issn 1078-0432, 9 p.Article

Case-control study of postmenopausal hormone replacement therapy and endometrial cancerSTROM, Brian L; SCHINNAR, Rita; REBBECK, Timothy R et al.American journal of epidemiology. 2006, Vol 164, Num 8, pp 775-786, issn 0002-9262, 12 p.Article

The oncogene phosphatidylinositol 3'-kinase catalytic subunit a promotes angiogenesis via vascular endothelial growth factor in ovarian carcinomaLIN ZHANG; NUO YANG; COUKOS, George et al.Cancer research (Baltimore). 2003, Vol 63, Num 14, pp 4225-4231, issn 0008-5472, 7 p.Article

Survival of BRCA1 negative ovarian cancer patients based on family historyCHU, Christina S; MORGAN, Mark A; RANDALL, Thomas C et al.Gynecologic oncology (Print). 2001, Vol 83, Num 1, pp 109-114, issn 0090-8258Conference Paper

p53 mutations and microsatellite instability in ovarian cancer: Yin and Yang. DiscussionBULLER, Richard E; SHAHIN, Mark S; HOLMES, Richard W et al.American journal of obstetrics and gynecology. 2001, Vol 184, Num 5, pp 891-903, issn 0002-9378Conference Paper

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group StudyBURGER, Robert A; BRADY, Mark F; LIM, Peter C et al.Journal of clinical oncology. 2014, Vol 32, Num 12, pp 1210-1217, issn 0732-183X, 8 p.Article

Intraepithelial T Cells and Tumor Proliferation: Impact on the Benefit From Surgical Cytoreduction in Advanced Serous Ovarian CancerADAMS, Sarah F; LEVINE, Douglas A; CADUNGOG, Mark G et al.Cancer. 2009, Vol 115, Num 13, pp 2891-2902, issn 0008-543X, 12 p.Article

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk : A Population-Based Case-Control StudyDEMICHELE, Angela; TROXEL, Andrea B; REBBECK, Timothy R et al.Journal of clinical oncology. 2008, Vol 26, Num 25, pp 4151-4159, issn 0732-183X, 9 p.Article

Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer : A Gynecologic Oncology Group StudyWINTER, William E; MAXWELL, G. Larry; CHUNQIAO TIAN et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 83-89, issn 0732-183X, 7 p.Article

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancersLIN ZHANG; NUO YANG; PARK, Jin-Wan et al.Cancer research (Baltimore). 2003, Vol 63, Num 12, pp 3403-3412, issn 0008-5472, 10 p.Article

Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancySRINIVASAN, Radhika; YANG, Yu-Xiao; RUBIN, Stephen C et al.Journal of clinical gastroenterology. 2007, Vol 41, Num 3, pp 291-296, issn 0192-0790, 6 p.Article

Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancerSRINIVASAN, Radhika; YANG, Yu-Xiao; RUBIN, Stephen C et al.The American journal of gastroenterology. 2005, Vol 100, Num 12, pp 2759-2764, issn 0002-9270, 6 p.Article

Delayed hemorrhage after cervical conization unmasking severe Factor XI deficiencyKIM, Sarah H; SRINIVAS, Sindhu K; RUBIN, Stephen C et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 104, Num 5, pp 1189-1192, issn 0029-7844, 4 p., 2Article

Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: A decision analysisARMSTRONG, Katrina; SCHWARTZ, J. Sanford; RANDALL, Thomas et al.Journal of clinical oncology. 2004, Vol 22, Num 6, pp 1045-1054, issn 0732-183X, 10 p.Article